评估 BRCA1 和 BRCA2 作为免疫检查点抑制剂反应的指标。
Evaluation of BRCA1 and BRCA2 as Indicators of Response to Immune Checkpoint Inhibitors.
机构信息
Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City.
出版信息
JAMA Netw Open. 2021 May 3;4(5):e217728. doi: 10.1001/jamanetworkopen.2021.7728.
Abstract
This cohort study examines the association of and with tumor mutation burden and response to immune checkpoint inhibitors.
摘要
本队列研究探讨了 和 与肿瘤突变负担以及对免疫检查点抑制剂反应的关系。
Zotero 插件